logo

For the Inventor, By the Inventor

Wilmington, NC, United States of America

Robert R Whittle

This inventor holds 39 USPTO granted patents and 1 EPO patent, primarily in Pharmaceutical Formulations. Top assignees: Duramed Pharmaceuticals, Inc., Endeavor Pharmaceuticals, Barr Laboratories, Inc.. Active years: 1998-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert R Whittle. Retrieved from https://idiyas.com/inventor/robert-r-whittle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 39

% Patents Active = 33.3

 

Average Co-Inventor Count = 3.0

ph-index = 12

Forward Citations = 621(Granted Patents)


Company Filing History:

goldMedal4 out of 14 
 
Duramed Pharmaceuticals, Inc.
 patents
silverMedal3 out of 3 
 
Endeavor Pharmaceuticals
 patents
bronzeMedal2 out of 16 
 
Barr Laboratories, Inc.
 patents
4. 30 out of 834,659 
Other
 patents

Years Active: 1998-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
Estrogenic Compounds
Pharmaceutical Compositions
Benzimidazole Compounds
Bioavailability Improvement
Polymorphic Forms
Topical Formulations
Granulated Formulations
Dry Blend Formulations
Unit Dosage Form
Conjugated Estrogens
Spectroscopic Measurement
Pharmaceutical Grinding
39 patents (USPTO):Explore Patents
1. 8227454 - Estrogenic compounds, pharmaceutical compositions and formulations comprising the same (2012-07-24),
2. 7989436 - Estrogenic compounds and pharmaceutical formulations comprising the same (2011-08-02),
3. 7749989 - Estrogenic compounds, methods of using and methods of administering the same (2010-07-06),
4. 7459445 - Estrogenic compounds and topical pharmaceutical formulations of the same (2008-12-02),
5. 7179799 - (3) and (6) substituted estrogenic compounds (2007-02-20),
6. 6992075 - C(14) estrogenic compounds (2006-01-31),
7. 6855703 - Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds (2005-02-15),
8. 6844334 - (3) and (6) substitued estrogenic compounds (2005-01-18),
9. 6780880 - FT-Raman spectroscopic measurement (2004-08-24),
10. 6706737 - Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same (2004-03-16),
11. 6673936 - Process for purifying 6-methoxy omeprazole (2004-01-06),
12. 6667324 - Dry blend pharmaceutical formulations (2003-12-23),
13. 6667323 - Dry-blend pharmaceutical formulations (2003-12-23),
14. 6667321 - Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same (2003-12-23),
15. 6660864 - Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone (2003-12-09),

Title: The Inventor Profile of Robert R Whittle

Introduction: Robert R Whittle is a renowned inventor based in Wilmington, NC, known for his groundbreaking contributions to various fields.

Latest Patents: Robert R Whittle holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of innovations.

Career Highlights: With a career spanning over two decades, Robert R Whittle has established himself as a leading figure in the world of inventions, with a keen focus on improving everyday life through his creations.

Collaborations: Throughout his career, Robert R Whittle has collaborated with top research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work across different sectors seamlessly.

Conclusion: Robert R Whittle's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…